Pre-admission anticoagulant therapy and mortality in hospitalized COVID-19 patients: A retrospective cohort study.
| Title: | Pre-admission anticoagulant therapy and mortality in hospitalized COVID-19 patients: A retrospective cohort study. |
|---|---|
| Authors: | van Haaps TF; Department of Vascular Medicine, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Center, Amsterdam, the Netherlands. Electronic address: t.f.vanhaaps@amsterdamumc.nl.; Collard D; Department of Vascular Medicine, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Center, Amsterdam, the Netherlands.; van Osch FHM; Department of Clinical Epidemiology, VieCuri Medical Center, Venlo, the Netherlands & NUTRIM, School for Nutrition and Translational Research in Metabolism, Maastricht University, Maastricht, the Netherlands.; Middeldorp S; Department of Vascular Medicine, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Center, Amsterdam, the Netherlands; Department of Internal Medicine & Radboud Institute of Health Sciences (RIHS), Radboud University Medical Center, Nijmegen, the Netherlands.; Coppens M; Department of Vascular Medicine, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Center, Amsterdam, the Netherlands.; de Kruif MD; Department of Pulmonary Medicine, Zuyderland Medical Centre, Heerlen, the Netherlands.; Vlot EA; Department of Anaesthesiology, Intensive Care and Pain Medicine, St Antonius Hospital, Nieuwegein, the Netherlands.; Douma RA; Department of Internal Medicine, Flevo Hospital, Almere, the Netherlands.; Ten Cate H; Department of Internal Medicine, Cardiovascular Research Institute Maastricht (CARIM) and Maastricht University Medical Center, Maastricht, the Netherlands.; Juffermans NP; Department of Intensive Care Medicine, Onze Lieve Vrouwe Gasthuis, Amsterdam, the Netherlands; Department of Intensive Care Medicine, Amsterdam University Medical Center, Amsterdam, the Netherlands.; Gritters N; Department of Intensive Care Medicine, Treant Zorggroep, Emmen, the Netherlands.; Vlaar AP; Department of Intensive Care Medicine, Amsterdam University Medical Center, Amsterdam, the Netherlands.; Reidinga AC; Department of Anaesthesiology, Martini Hospital, Groningen, the Netherlands.; Heuvelmans MA; Institute of Diagnostic Accuracy (iDNA), Groningen, the Netherlands.; Oudkerk M; Institute of Diagnostic Accuracy (iDNA), Groningen, the Netherlands.; Büller HR; Department of Vascular Medicine, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Center, Amsterdam, the Netherlands.; van den Bergh JPW; Department of Internal Medicine, VieCuri Medical Center, Venlo, the Netherlands.; Maas A; Department of Internal Medicine, VieCuri Medical Center, Venlo, the Netherlands.; Ten Wolde M; Department of Internal Medicine, Flevo Hospital, Almere, the Netherlands.; Simsek S; Department of Internal Medicine, Northwest Clinic, Alkmaar, the Netherlands.; Beudel M; Department of Neurology, Amsterdam UMC, Amsterdam Neuroscience Institute, Amsterdam, the Netherlands.; van Es N; Department of Vascular Medicine, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Center, Amsterdam, the Netherlands. |
| Corporate Authors: | Corona Research Fund Amsterdam UMC; Dutch COVID & Thrombosis Coalition |
| Source: | Thrombosis research [Thromb Res] 2021 Dec; Vol. 208, pp. 35-38. Date of Electronic Publication: 2021 Oct 15. |
| Publication Type: | Letter; Comment |
| Language: | English |
| Journal Info: | Publisher: Pergamon Press Country of Publication: United States NLM ID: 0326377 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-2472 (Electronic) Linking ISSN: 00493848 NLM ISO Abbreviation: Thromb Res Subsets: MEDLINE |
| Imprint Name(s): | Original Publication: Elmsford, N. Y., Pergamon Press. |
| MeSH Terms: | COVID-19*; Anticoagulants/therapeutic use ; Hospital Mortality ; Humans ; Retrospective Studies ; SARS-CoV-2 |
| Comments: | Comment on: N Engl J Med. 2021 Aug 26;385(9):777-789. doi: 10.1056/NEJMoa2103417.. (PMID: 34351722) |
| References: | N Engl J Med. 2021 Aug 26;385(9):777-789. (PMID: 34351722); Am Heart J. 2021 May;235:12-23. (PMID: 33577800); Lancet. 2021 Jun 12;397(10291):2253-2263. (PMID: 34097856); Res Pract Thromb Haemost. 2020 Oct 13;4(7):1178-1191. (PMID: 33043231); J Am Coll Cardiol. 2020 Jul 7;76(1):122-124. (PMID: 32387623); Blood. 2020 Jul 2;136(1):144-147. (PMID: 32462179) |
| Contributed Indexing: | Keywords: Anticoagulants; COVID-19; Mortality; SARS-CoV-2; Thrombosis |
| Substance Nomenclature: | 0 (Anticoagulants) |
| Entry Date(s): | Date Created: 20211023 Date Completed: 20211223 Latest Revision: 20221217 |
| Update Code: | 20260130 |
| PubMed Central ID: | PMC8518131 |
| DOI: | 10.1016/j.thromres.2021.10.006 |
| PMID: | 34688100 |
| Database: | MEDLINE |
Letter; Comment